| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.002 |